Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2002

View Archived Issues

Supplementation with oral L-arginine inhibits transdermal nitrate tolerance

Potential use of allopurinol in endothelial dysfunction associated with chronic heart failure

Osteoprotegerin deficiency described as a possible cause of juvenile Paget's disease

Cubist acquires rights to CAB-175

Inamed acquires rights to botulinum toxin type A

Thuris and Praecis collaborate on age-related compound development

Atrix submits IND for new dosage form of Eligard

Introgen to file European Advexin marketing application in 2004

AltaRex's OvaRex receives E.U. orphan drug designation for ovarian cancer

Positive results for ursodiol in colorectal cancer

Sangart reports positive data for Hemospan

Avant completes phase II CETi-1 trial enrollment

New anti-herpes virus drugs in early development at GSK

FDA advisory committee recommends approval of adefovir dipivoxil for chronic hepatitis B

AstraZeneca completes Iressa NDA for NSCLC

Bayer claims new PDE10A inhibitors and their use in cancer

Servier researchers identify new metalloproteinase inhibitors

Factor Xa/factor VIIa inhibitors reported by Aventis

HCV NS3 protease inhibitors prepared and tested at Schering-Plough